SCHEMBL6204068

SCHEMBL6204068

COC([O])c1cccc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.50
KDM4E B2RXH2 1/20 0.46
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
CNR2 P34972 1/20 0.41
ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3743698 0.79 AOC3 (0.53) AOC3KDM4EHDAC4HDAC7HDAC5
SCHEMBL792133 0.79 IDO1 (0.56) AOC3KDM4EHDAC4HDAC7HDAC5
SCHEMBL6204937 0.79 CES2 (0.38) AOC3KDM4EIDO1TDO2CES2
SCHEMBL15854161 0.78 AOC3 (0.56) AOC3KDM4EHDAC4HDAC7HDAC5
SCHEMBL17112350 0.78 AOC3 (0.56) AOC3KDM4EHDAC4HDAC7HDAC5
SCHEMBL6205041 0.78 IDO1 (0.46) IDO1TDO2
SCHEMBL5168017 0.78 AOC3 (0.49) AOC3ACHE
SCHEMBL14018507 0.77 AOC3 (0.47) AOC3KDM4EHDAC4HDAC7HDAC5
SCHEMBL1046557 0.77 HDAC4 (0.48) AOC3KDM4EHDAC4HDAC7HDAC5
SCHEMBL792296 0.76 ACHE (0.48) AOC3HDAC4HDAC7HDAC5IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101910178-A Gamma secretase modulators SCHERING CORP 2010-12-08 CN disclosed
CN-1668601-A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors JANSSEN PHARMACEUTICA NV (BE) 2005-09-14 CN disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed